AbbVie to Present at Citi's 2024 Global Healthcare Conference

ABBV 11.25.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-03
Name of Upcoming Event:Citi's 2024 Global Healthcare Conference
Full Press ReleaseSEC FilingsOur ABBV Tweets

About Gravity Analytica

Recent News

  • 01.31.2025 - AbbVie to Host Fourth Quarter 2024 Earnings Conference Call
  • 01.15.2025 - J.P. Morgan Healthcare Conference
  • 01.03.2025 - AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

Recent Filings

  • 01.10.2025 - 8-K Current report
  • 01.06.2025 - EX-99.1 EX-99.1
  • 01.03.2025 - 4 Statement of changes in beneficial ownership of securities

NORTH CHICAGO, Ill.,Nov. 25, 2024/PRNewswire/ --AbbVie(NYSE: ABBV) will participate in Citi's 2024 Global Healthcare Conference onTuesday, December 3, 2024.Scott T. Reents, executive vice president, chief financial officer,Jeffrey R. Stewart, executive vice president, chief commercial officer andRoopal Thakkar, M.D., executive vice president, Research & Development and chief scientific officer, will present at9:15 a.m. Central time.

A live audio webcast of the presentation will be accessible throughAbbVie's Investor Relations website atinvestors.abbvie.com. An archived edition of the session will be available later that day.

AboutAbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information aboutAbbVie, please visit us atwww.abbvie.com. Follow @abbvie onLinkedIn,Facebook,Instagram,X (formerly Twitter), andYouTube.

AbbVie logo

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-citis-2024-global-healthcare-conference-302314669.html

SOURCEAbbVie

Media: Gabby Tarbert, (224) 244-0111, gabrielle.tarbert@abbvie.com, or Investors: Liz Shea, (847) 935-2211, liz.shea@abbvie.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com